Equities research analysts at StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the stock.
Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.
Get Our Latest Research Report on STRM
Streamline Health Solutions Stock Performance
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last released its earnings results on Monday, December 16th. The company reported ($0.61) EPS for the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.
About Streamline Health Solutions
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Featured Stories
- Five stocks we like better than Streamline Health Solutions
- Transportation Stocks Investing
- Micron Stock Under $100: Seize the AI-Driven Upside
- Options Trading – Understanding Strike Price
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.